AdaptHealth Corp. (AHCO) Presents at Bank of America Global Healthcare Conference 2026 Transcript
RBC Capital Maintains Outperform on AdaptHealth, Raises Price Target to $15
AdaptHealth Corp. 2026 Q1 - Results - Earnings Call Presentation
Canaccord Genuity Maintains Buy on AdaptHealth, Raises Price Target to $16
UBS Maintains Buy on AdaptHealth, Lowers Price Target to $14
AdaptHealth Corp. (AHCO) Q1 2026 Earnings Call Transcript
AdaptHealth Corp. (NASDAQ:AHCO) Q1 Revenue Beat Overshadowed by Profit Miss, Shares Fall 5%
CORRECTION: AdaptHealth Q1 Adj. EPS $(0.05) Misses $0.02 Estimate, Sales $819.799M Beat $796.621M Estimate
AdaptHealth Raises FY2026 Sales Guidance from $3.440B-$3.510B to $3.450B-$3.520B vs $3.463B Est
Truist Securities Maintains Buy on AdaptHealth, Raises Price Target to $14
Is AUNA S.A. a Solid Investment Opportunity Post Q4 Earnings?
How Auna S.A. Is Heading Toward Its Net Leverage Target
Insiders Are Buying These 3 Beaten-Down Stocks. Should You Follow?
AdaptHealth (AHCO) Shares Skyrocket, What You Need To Know
Assessing AdaptHealth (AHCO) Valuation After Recent Share Price Weakness
Unpacking Q4 Earnings: AdaptHealth (NASDAQ:AHCO) In The Context Of Other Senior Health, Home Health & Hospice Stocks
AdaptHealth Conference: CFO Details CPAP Recurring Revenue, Faster Setups, and Capitated Contract Growth
AdaptHealth Corp. (AHCO) Presents at J.P. Morgan 2026 Global Leveraged Finance Conference Transcript
1 Stock Under $50 with Impressive Fundamentals and 2 We Brush Off
AdaptHealth Resets Earnings As Capitated Contract And Debt Raise Execution Risk
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.